Regressing and progressing metastatic lesions: Resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

  1. Aptsiauri, N.
  2. Carretero, R.
  3. Garcia-Lora, A.
  4. Real, L.M.
  5. Cabrera, T.
  6. Garrido, F.
Journal:
Cancer Immunology, Immunotherapy

ISSN: 0340-7004

Year of publication: 2008

Volume: 57

Issue: 11

Pages: 1727-1733

Type: Conference paper

DOI: 10.1007/S00262-008-0532-3 GOOGLE SCHOLAR
Data source: Scopus